Ameritas Investment Partners, Inc. Trevena Inc Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.2 - $0.5 $2,564 - $6,411	-12,822 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$1.46 - $2.25 $18,720 - $28,849	12,822 New	12,822 $22,000
Q2 2018 Aug 13, 2018	SELL	$1.44 - $2.24 $5,019 - $7,808	-3,486 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	3,486	3,486 $8,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $292M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.